NASDAQ:ALZN   Alzamend Neuro, Inc.
$ALZN (Alzamed Neuro Inc) is a preclinical stage biopharmaceutical company focused on developing products for the treatment of neurodegenerative diseases and psychiatric disorders.
It seems to be creating a demand zone with bullish RSI divergence and good spikes at volume.
Invalidation with a daily close under 4,42$.
Daily chart.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。